RORa can inhibit tumour cell proliferation and epithelial-mesenchymal transition (EMT)52 and has been identified as a negative regulator of the Wnt/β-catenin pathway and potential tumour suppressor in multiple cancers53,54. This evidence concerns the gene RORA and neoplasm.